Epilepsy Guidelines for Women: What a Systematic Review Found
Researchers systematically reviewed clinical practice guidelines for women with epilepsy published in English or Korean from January 2014 through December 2024.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
Researchers systematically reviewed clinical practice guidelines for women with epilepsy published in English or Korean from January 2014 through December 2024.
Researchers conducted a multicentre, observational, longitudinal study of 4,804 adults with Down syndrome from seven international cohorts.
Researchers systematically reviewed 14 randomized controlled trials involving 516 adults with epilepsy, including adults with drug-resistant focal epilepsy.
This systematic review examined whether déjà vu, déjà vécu, dreamy states, and reminiscence during focal seizures can help identify the epileptogenic zone.
This multicenter retrospective study reviewed clinical records from 61 people with genetically confirmed Dravet syndrome.
This systematic review examined associations between climate-related exposures and seizures in children age 18 or younger, including children with and without diagnosed epilepsy.
This prospective observational study followed 365 critically ill children with acute encephalopathy who underwent clinically indicated continuous EEG monitoring in a pediatric intensive care unit.
This systematic review examined medium-chain triglyceride (MCT)-based interventions for people with drug-resistant epilepsy.
This nationwide Taiwan study included 2,583,503 people born from 2001 through 2016 and followed through 2021.